Nanoparticle Targeting with Antibodies in the Central Nervous System

Treatments for disease in the central nervous system (CNS) are limited because of difficulties in agent penetration through the blood-brain barrier, achieving optimal dosing, and mitigating off-target effects. The prospect of precision medicine in CNS treatment suggests an opportunity for therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju Hyun, Chapman, Dana V., Saltzman, W. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AAAS 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085254/
https://www.ncbi.nlm.nih.gov/pubmed/37849659
http://dx.doi.org/10.34133/bmef.0012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085254/
https://www.ncbi.nlm.nih.gov/pubmed/37849659
http://dx.doi.org/10.34133/bmef.0012

Ejemplares similares